Stay updated on Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial

Sign up to get notified when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The top revision badge updated from v3.3.3 to v3.3.4, indicating a minor update.
    Difference
    0.0%
    Check dated 2026-01-14T03:27:51.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    - Removed related topics: 'Multiple myeloma' and 'MedlinePlus Genetics' from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-30T22:45:22.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Locations section now lists New Jersey as the study site. HHS Vulnerability Disclosure link removed and page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T21:08:27.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added related topics: "Multiple myeloma" and "MedlinePlus Genetics" to the Related Topics section. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-16T20:02:49.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-12-09T17:09:39.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    Added related topic tags: 'Multiple myeloma' and 'MedlinePlus Genetics' to the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-02T16:26:54.000Z thumbnail image

Stay in the know with updates to Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.